Cannabis in Gastrointestinal Disorders
Explores effects on the gastrointestinal system, including inflammatory bowel disease, irritable bowel syndrome, nausea, and appetite modulation. Mechanistic insights into gut-brain interactions and microbiome modulation are discussed. Clinical evidence, innovative delivery strategies, and safety considerations are highlighted. Personalized treatment approaches for GI disorders are presented. Future research directions for gastrointestinal-focused therapies are proposed.
Related Conference of Cannabis in Gastrointestinal Disorders
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France